首页 | 本学科首页   官方微博 | 高级检索  
   检索      


TGF-β in Toxoplasmosis: Friend or foe?
Institution:1. Inserm, U955, Equipe 16, Créteil, 94000, France;2. Université Paris Est, Faculté de médecine, Créteil, 94000, France;3. Vaccine Research Institute (VRI), Créteil, 94000, France;4. Groupe Hospitalier Henri-Mondor Albert-Chenevier, 94010 Créteil, France;1. Department of Pharmacology, Faculty of Pharmacy, Misr University for Science and Technology, Cairo, Egypt;2. Department of Pharmacology, Faculty of Pharmacy, Cairo University, Cairo, Egypt;3. Pharmacology & Toxicology Department, Faculty of Pharmacy, Fayoum University, Fayoum, Egypt
Abstract:Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan causing several forms of toxoplasmosis in humans. The main mechanisms that allow the development of the prolonged forms of the disease and its subsequent pathology are yet to be clarified. However, many researchers have hypothesized that immunological and genetic parameters may play crucial roles in the etiology of the disease. Transforming growth factor beta (TGF-β) is a cytokine with a dual role in the regulation of immune responses including those against parasites. However, the relationship between TGF-β and immune responses against T .gondii are not fully understood. The important roles played by TGF-β in the development of Th17 and T regulatory lymphocytes, mucosal immunity and regulation of immune responses have been documented and this provides insights into TGF-β function during parasitic infections such as toxoplasmosis. Therefore, the aim of this review is to collate the current information regarding the status and association of TGF-β with T. gondii infection.
Keywords:TGF-β  Th17  T regulatory lymphocytes
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号